Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518258
Status:
COMPLETED
Last Update Posted:
2013-05-17
First Post:
2007-08-16
Brief Title:
Neuroimaging Studies of Depression in Parkinsons Disease
Sponsor:
Lee Blonder
Organization:
University of Kentucky
Study Overview
Official Title:
Neuroimaging Studies of Depression in Parkinsons Disease
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate similarities and differences in the neural pathways of depressed Parkinsons patients non-depressed Parkinsons patients and healthy controls using magnetic resonance imaging MRI of the brain and neuropsychological assessment
Detailed Description:
Depression is a common and potentially serious complication of Parkinsons disease PD Studies show that approximately 40 percent of PD patients are depressed There is evidence that these patients have deficits in neuropsychological function relative to non-depressed PD patients Despite the widespread toll on emotional health posed by PD few studies have undertaken a comprehensive examination of the neural underpinnings of Parkinsonian depression In this project we will compare depressed versus non-depressed Parkinson patients to a sample of demographically-matched healthy controls using neuropsychological assessment and magnetic resonance imaging MRI To investigate possible effects of anti-Parkinsonian medication on mood cognitive function and neural response PD patients will be tested both off and on Parkinsonian medications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None